Eppendorf invests in Swiss startup BigOmics

Eppendorf has made a strategic investment in BigOmics Analytics SA, a software company from Switzerland that develops digital cloud-based self-service tools to analyse molecular biology research data. The investment was initiated and carried out by the Eppendorf Innovation Company (EpIC), which serves as Eppendorf’s interface to innovative startups. EpIC is tasked with identifying and successfully implementing novel business models and promising partnerships for Eppendorf. To this end, EpIC is in close contact with the very dynamic international startup scene in the life science and biotechnology sector. EpIC’s scope includes areas such as liquid biopsy, innovative approaches to sample preparation for multi-omics and digital solutions for improving laboratory processes.